Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Chronic obstructive pulmonary disease: diagnosis and management.

Kaufman G.

Nurs Stand. 2013 Jan 23-29;27(21):53-7, 60-2.

PMID:
23427687
2.

An overview of assessment and management in COPD.

Barnett M.

Br J Community Nurs. 2009 May;14(5):195-201. Review.

PMID:
19421083
3.

The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.

Hanania NA.

Pulm Pharmacol Ther. 2008;21(3):540-50. doi: 10.1016/j.pupt.2007.12.004. Epub 2008 Jan 6. Review.

PMID:
18280761
5.

Management of stable chronic obstructive pulmonary disease.

Grindrod K.

Br J Community Nurs. 2015 Feb;20(2):58, 60-4. doi: 10.12968/bjcn.2015.20.2.58. Review.

PMID:
25651279
6.
7.

[Chronic obstructive pulmonary disease (COPD). Current concepts and new therapeutic options].

Klemmer A, Greulich T, Koczulla AR, Vogelmeier CF.

Internist (Berl). 2014 Apr;55(4):401-14. doi: 10.1007/s00108-013-3406-5. Review. German.

PMID:
24577341
9.

[Diagnosis and management of chronic obstructive pulmonary disease].

Malakauskas K, Sakalauskas R.

Medicina (Kaunas). 2005;41(2):171-9. Review. Lithuanian.

10.

Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options.

Rogers DF.

Pulm Pharmacol Ther. 2005;18(1):1-8. Review.

PMID:
15607121
11.

Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.

Wilt TJ, Niewoehner D, MacDonald R, Kane RL.

Ann Intern Med. 2007 Nov 6;147(9):639-53. Review.

PMID:
17975187
12.

Anticholinergics in the treatment of chronic obstructive pulmonary disease.

Beeh KM, Welte T, Buhl R.

Respiration. 2002;69(4):372-9. Review.

PMID:
12169757
13.

Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease.

Centanni S, Di Marco F.

Expert Opin Pharmacother. 2005 Nov;6(14):2525-34. Review. Erratum in: Expert Opin Pharmacother. 2005 Dec;6(15):2779.

PMID:
16259583
14.

Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena.

Halpin D.

COPD. 2008 Jun;5(3):187-200. doi: 10.1080/15412550802093041. Review.

15.

Innovations to achieve excellence in COPD diagnosis and treatment in primary care.

Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.

Postgrad Med. 2010 Sep;122(5):150-64. doi: 10.3810/pgm.2010.09.2212. Review.

PMID:
20861599
16.
17.

[New beta2-agonists in asthma and COPD].

Chyrek-Borowska S, Rogalewska AM.

Pneumonol Alergol Pol. 2002;70 Suppl 1:58-61. Review. Polish. No abstract available.

PMID:
12580164
19.
20.

Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.

Matera MG, Martuscelli E, Cazzola M.

Pulm Pharmacol Ther. 2010 Feb;23(1):1-8. doi: 10.1016/j.pupt.2009.10.001. Epub 2009 Oct 13. Review.

PMID:
19833222

Supplemental Content

Support Center